<DOC>
	<DOCNO>NCT01424176</DOCNO>
	<brief_summary>This multicenter , open-label , single-dose , PK safety study subject various stage renal impairment .</brief_summary>
	<brief_title>Dexpramipexole Renal PK Study</brief_title>
	<detailed_description>Dexpramipexole ( BIIB050 , KNS-760704 ; ( 6R ) -4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazolediamine dihydrochloride monohydrate ) synthetic amino-benzothiazole . Data multiple vitro vivo assay suggest dexpramipexole neuroprotective . It investigate treatment ALS . As dexpramipexole principally eliminate body kidney single oral dose dexpramipexole administer subject various stage renal impariment comprise follow category : mild , moderate , severe ESRD subject . Healthy volunteer match catergory renal impaired subject .</detailed_description>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Pramipexole</mesh_term>
	<criteria>Adult males/females age 18 75 year inclusive 19 36 kg/m2 inclusive BMI . Subjects renal impairment must stable renal disease ( i.e. , change disease status within 28 day prior dose ) determine Investigator laboratory clinical finding support diagnosis renal impairment . Subjects renal impairment ( exclude ESRD subject ) , must 2 separate estimate creatinine clearance within 25 % , obtain &gt; 5 day apart , &gt; 6 month apart Subjects must GFR ( estimate GFR ; define estimation creatinine clearance use MDRD formula ) ≥80 ( healthy volunteer ) , 50 79 ( mild renal impairment ) , 30 49 ( moderate renal impairment ) , &lt; 30 ( severe renal impairment ) , must require dialysis ≤3 time week ( ESRD ) . Healthy volunteer must match renally impaired subject age ( ± 10 year ) , gender , possible BMI ( ± 20 % ) . Healthy volunteer receive prescription medication within 14 day prior dose ( except birth control ) . Renally impaired subject receive prescription medication within 14 day prior dose ( except birth control medication take stable dose underlying condition , determine Investigator ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>